In a special episode of the pharmaphorum #podcast, editor-in-chief Jonah Comstock sat down with Deep Dive editor Eloise McLennan to discuss key takeaways from #LSXWorldCongressUSA. From evolving #investment trends like #AI in #biotech and #digital to emerging areas such as precision psychiatry, they explore the cautiously optimistic investment landscape, the delicate balance between early- and late-stage investments, and the importance of building honest, productive relationships across the #healthcare ecosystem. https://lnkd.in/eRvrKhaq
pharmaphorum
Media Production
London, England 10,513 followers
Industry leading publications, strategic consulting and a content-driven stakeholder engagement agency
About us
pharmaphorum.com, and its associated digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate. www.pharmaphorum.com
- Website
-
https://pharmaphorum.com/about/
External link for pharmaphorum
- Industry
- Media Production
- Company size
- 11-50 employees
- Headquarters
- London, England
- Type
- Privately Held
- Founded
- 2009
- Specialties
- pharmaceuticals, media, biotech, networking, marketing, sales, R&D, devices, diagnostics, commercial, content, communications, creative, consulting, publishing, market access, patients, digital health, and oncology
Locations
-
Primary
6 Kean Street
5th Floor
London, England WC2B 4AS, GB
Employees at pharmaphorum
Updates
-
NEWS: Australian drugs regulator won't approve Eisai and Biogen's #Alzheimers drug Leqembi, saying its efficacy does not outweigh its risks, but Eisai plans to appeal https://lnkd.in/eBKGMCMF
Australia joins EU in turning down Alzheimer's drug Leqembi
pharmaphorum.com
-
The ESMO - European Society for Medical Oncology congress always disseminates the latest results of #cancerresearch, a vibrant gathering and sharing of the latest data, communicating the next promising steps in oncological scientific development, ever seeking to address unmet patient needs. In this #podcast, pharmaphorum Web Editor Nicole R. speaks with experts from EVERSANA about their takeaways from the 2024 conference. Tune in to hear more from: Anne Marie Robertson, Chief Commercial Officer, EVP, EVERSANA COMPLETE Oncology, EVERSANA; Barry Vucsko, Senior Vice President, Client Services and Business Development Leader, EVERSANA INTOUCH; Vanitha Sankaran, VP, Medical Strategy, EVERSANA INTOUCH; and Gurdip Daffu, PhD, VP, Medical Strategy (Oncology), EVERSANA INTOUCH. https://lnkd.in/eTpxf3Q8
Oncology today: EVERSANA and pharmaphorum at ESMO 2024
pharmaphorum.com
-
And Frontiers Health has begun! Are you in Berlin, listening to the insights and discussions - or taking part in a few of your own during the many networking opportunities - at the conference? If not, be sure to tune into our #liveblog today and tomorrow, to keep up to date with the conversation. https://lnkd.in/enAC3aue
Frontiers Health 2024: Day One
pharmaphorum.com
-
NEWS: The first human skin map is helping researchers to understand how skin forms and the mechanisms behind disorders - and could usher in scarless skin healing #Nature #humancellatlas #dermatology https://bit.ly/3Yp38tE
First human skin atlas points way to healing without scars
pharmaphorum.com
-
NEWS: NIH study finds Bavarian Nordic's #mpox vaccine is effective in adolescents, a particularly vulnerable group amid the ongoing outbreak https://bit.ly/3Y8stXp
NIH study backs Bavarian Nordic mpox jab for adolescents
pharmaphorum.com
-
NEWS: Shares in #WaveLifeSciences surge 74% after it reports clinical data with a pioneering #RNAediting therapy for alpha-1 antitrypsin deficiency. #AATD https://lnkd.in/er4sPMFN
Wave surges on first RNA editing data in humans
pharmaphorum.com
-
In August, the US Centers for #Medicare and #Medicaid Services released the negotiated prices for the first 10 drugs subject to the drug negotiation provisions in the #InflationReductionAct. In this #podcast, host Jonah Comstock is joined by Alice Valder Curran, a partner at Hogan Lovells and a healthcare policy expert, for a broad ranging discussion of some of the next steps and consequences – intended or otherwise – of this #legislation. https://lnkd.in/eAPuXxRP
Medicare drug pricing negotiations: What comes next?
pharmaphorum.com
-
With the fast-paced #techtransformation of the #healthcaremarketing industry taking place, making the right choices when selecting #pointofcare (POC) marketing partners can make or break a campaign’s success. Doceree's Kamya Elawadhi explains. https://lnkd.in/eQqt6f8q
Importance of choosing the right POC marketing partners in healthcare
pharmaphorum.com
-
NEWS: Despite efforts to raise diversity in #clinicaltrials, a study in head and neck cancer found the trend in the US is going in the other direction. #oncology #clinicalequality https://lnkd.in/eig5bfbm
Head and neck cancer trials 'becoming less diverse'
pharmaphorum.com